Objective-The c-Jun NH 2 -terminal kinases (JNK) are regulated by a wide variety of cellular stresses and have been implicated in apoptotic signaling. Macrophages express 2 JNK isoforms, JNK1 and JNK2, which may have different effects on cell survival and atherosclerosis. Approach and Results-To dissect the effect of macrophage JNK1 and JNK2 on early atherosclerosis, Ldlr −/− mice were reconstituted with wild-type, Jnk1 −/− , and Jnk2 −/− hematopoietic cells and fed a high cholesterol diet. Jnk1 −/− →Ldlr −/− mice have larger atherosclerotic lesions with more macrophages and fewer apoptotic cells than mice transplanted with wildtype or Jnk2 −/− cells. Moreover, genetic ablation of JNK to a single allele (Jnk1 +/− /Jnk2 −/− or Jnk1 −/− /Jnk2 +/− ) in marrow of Ldlr −/− recipients further increased atherosclerosis compared with Jnk1 −/− →Ldlr −/− and wild-type→Ldlr −/− mice. In mouse macrophages, anisomycin-mediated JNK signaling antagonized Akt activity, and loss of Jnk1 gene obliterated this effect. Similarly, pharmacological inhibition of JNK1, but not JNK2, markedly reduced the antagonizing effect of JNK on Akt activity. Prolonged JNK signaling in the setting of endoplasmic reticulum stress gradually extinguished Akt
M acrophages play central roles in the development of atherosclerosis through modulation of cholesterol homeostasis, the immune-inflammatory response, and plaque cellularity. 1 Macrophage activation and survival are crucial determinants of atherosclerotic lesion development. 2 In addition, macrophages contribute to the integration of immune and metabolic responses, and their dysfunction contributes to chronic metabolic disorders, such as obesity, type 2 diabetes mellitus, and cardiovascular disease. 3 The c-Jun NH 2 -terminal kinases (JNK) belong to the stressactivated protein kinase family, which are activated by a variety of environmental (radiation, osmotic, and redox stress) and metabolic stresses, cytokines, and growth factors. 4, 5 JNK plays an important role in inflammatory signaling, and its activation is crucial for programmed cell death. 6 In mammals, the JNK protein kinases are encoded by 3 genes: Jnk1, Jnk2 and Jnk3, which transcribe several alternatively spliced isoforms. 7 Jnk1 and Jnk2 genes are expressed ubiquitously, whereas the Jnk3 gene is restricted to the brain, cardiac smooth muscle, pancreatic islets, and testis. 4 The targeted disruption of the Jnk1 or Jnk2 genes revealed that they compensate for each other's activity and are functionally redundant, 8 but each isoform also exhibits distinct roles. 9 For example, activation of CD8 + T cells is impaired in Jnk1 knockout mice but enhanced in Jnk2 null mice. 10 Loss of Jnk1, but not Jnk2, suppresses obesity and improves insulin sensitivity in mice. 11 JNK1, but not JNK2, activation plays an important role in the pathogenesis of insulin resistance. [12] [13] [14] Examination of cell types involved in metabolic functions of JNK illustrated contributions from many stromal cell types, including neuronal cells, adipocytes, and hepatocytes. 14, 15 Several studies also demonstrated the involvement of macrophage JNK activity at varying degrees in obesity and insulin resistance. 8, 12, 14 Ricci et al 16 have shown that apoE null (apoE −/− ) mice lacking Jnk2 (apoE −/− /Jnk2 −/− mice) develop less atherosclerosis than apoE −/− or apoE −/− /Jnk1 −/− mice. The effect of loss of Jnk2 on atherosclerosis was attributed to reduced scavenger receptor A expression and foam cell formation by macrophages. 16 However, the role of macrophage JNK isoforms on apoptosis in the setting of atherosclerosis was not assessed, and additional studies are needed to evaluate the role of individual macrophage JNK isoforms in atherogenesis. 5 JNK signaling has been implicated in apoptosis in response to a variety of stress stimuli. 4, 6 Although both JNK1 and JNK2 are involved in apoptotic signaling, only JNK1 is considered to be essential for apoptosis. 17 Murine embryonic fibroblasts lacking Jnk1, but not Jnk2, have reduced c-Jun phosphorylation and ultraviolet-induced cell death. 18 Loss of both Jnk1 and Jnk2 in murine embryonic fibroblasts produces a defect in death signaling and protects them from apoptosis. 19 Interestingly, the role of JNK in apoptosis depends on the activity of other cellular signaling pathways, including the prosurvival phosphatidylinositol-3-kinase (PI3K/Akt). 20, 21 Aikin et al 22 were the first to report cross talk between the PI3K/Akt and JNK pathways that protects islet cells from apoptosis. In addition, Sunayama et al 23 have shown that JNK signaling antagonizes Akt activity in mammalian cells making them more susceptible to apoptosis. Similarly, JNK inhibition significantly suppresses pancreatic β-cell death 24 and decreases macrophage apoptosis. 25 Interestingly, phosphatase and tensin homolog (PTEN) may play a key role in the cross talk between the PI3K/Akt and JNK pathways, and PTEN deficiency impairs negative feedback regulation of PI3K in cancer cells. 26 However, the precise role of JNK signaling in apoptosis depends on the cell type and the nature of the death stimulus. 6, 17 It is unclear whether JNK antagonizes Akt activity in mouse macrophages or whether this cross talk is mediated via PTEN with consequent suppression of cell survival that affects atherogenesis.
Here, we used genetic loss-of-function and pharmacological inhibition approaches to investigate the effect of JNK1 and JNK2 on Akt signaling in mouse macrophages and atherogenesis. Our data demonstrate the critical role of JNK1 signaling in macrophage apoptosis and development of early atherosclerosis.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

JNK Deficiency in Hematopoietic Cells Increases Early-Stage Atherosclerotic Lesions
To examine the effect of hematopoietic cell Jnk1 and Jnk2 deficiency on atherosclerosis, 22-week-old male Ldlr −/− mice were lethally irradiated and transplanted with male wild-type (WT; n=14), Jnk1 −/− (n=11), or Jnk2 −/− (n=13) bone marrow. After 4 weeks on a normal chow diet, mice were fed with the Western diet for another 8 weeks. No significant differences between the recipient groups were detected in body weight, serum total cholesterol, and triglyceride levels on the chow and the Western diets (Table, A ). Size exclusion chromatography of serum revealed an accumulation of cholesterol in very lowdensity lipoprotein, low-density lipoprotein, and intermediate-density lipoproteins fractions in Ldlr −−/− recipients with no differences between control and experimental groups in either experiment (data not shown). Mice reconstituted with WT, Jnk1 −/− , and Jnk2 −/− marrow had similar levels of blood glucose (133.7±5.3, 139±6.8, and 137±6.7 mg/dL, respectively), Values are in mg/dL (mean±SEM). The number of recipient mice in each group is indicated by n. The differences are not statistically significant between the groups by 1-way ANOVA. BW indicates body weight; TC, total serum cholesterol; TG, triglyceride; and WT, wild-type. erythrocytes (9.7±0.8, 9.9±1.1, and 9.7±0.9×10 6 /μL), platelets (649±66, 679±73, and 613±61×10 3 /μL), and white blood cells (7.8±06, 9.1±0.7, and 7.5±0.45×10 6 /mL). In contrast, the extent of atherosclerotic lesions in aortic sinus of the Jnk1 −/− → Ldlr −/− mice was markedly increased ( Figure 1A and 1B) compared with mice reconstituted with WT or Jnk2 −/− marrow cells ( Figure 1B ; 241.6±38.1 versus 110.8±13.4 and 95.8±17.6×10 3 μm 2 , respectively). Similarly, Jnk1 −/− →Ldlr −/− mice had significantly increased size of atherosclerotic lesions in the distal aorta compared with WT→ Ldlr −/− and Jnk2 −/− → Ldlr −/− mice ( Figure 1C and 1D; 0.67%±0.22% versus 0.31%±0.10% and 0.24%±0.07%, respectively).
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Next, examination of the cellular composition of atherosclerotic lesions in the aortic sinus of recipients showed that the proportion of smooth muscle, T, and B cells in atherosclerotic lesions did not differ significantly between the 3 groups (data not shown). The lesions predominantly consisted of macrophage-derived foam cells, and Jnk1 −/− →Ldlr −/− mice had significantly bigger lesion area stained with antibody to MOMA-2 versus WT→Ldlr −/− and Jnk2 −/− →Ldlr −/− mice ( Figure 1A ; 167.1±29.4 versus 82.4±10.3 and 76.4±4.6×10 3 μm 2 , respectively). The analysis of serial aortic sections stained with MOMA-2 and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) revealed that Jnk1 −/− →Ldlr −/− mice contained significantly fewer numbers of apoptotic cells in macrophage-rich areas of lesions than WT→Ldlr −/− and Jnk2 −/− →Ldlr −/− mice ( Figure 1E and 1F). Double staining of macrophages with MOMA-2 and cell nuclei with DAPI revealed increased (153%) numbers of nuclei per macrophage lesion area in Jnk1 −/− →Ldlr −/− mice compared with lesions of WT→Ldlr −/− and Jnk2 −/− →Ldlr −/− mice ( Figure 1G ). Together, the data indicate that the lack of Jnk1 in hematopoietic cells increases the burden of early atherosclerotic lesions in the absence of changes in plasma lipid or glucose levels. The dramatic increase of macrophage numbers together with reduced apoptosis in atherosclerotic lesions of Jnk1 −/− →Ldlr −/− mice also suggested changes in viability of JNK1 −/− macrophages in vivo. 
Genetic Ablation to a Single JNK Allele Further Increases Atherosclerosis
Peritoneal macrophages isolated from Jnk1 −/− →Ldlr −/− and Jnk 2 −/− →Ldlr −/− mice exhibited a significant decrease in JNK protein content compared with WT cells (Figure 2A ; 0.49±0.03 and 0.54±0.03 versus 1.0±0.01; P<0.05 by 1-way ANOVA) and JNK kinase activity ( Figure I in the online-only Data Supplement). They also had minimal residual expression of the knocked out isoform with compensatory increased expression of the other isoform ( Figure 2B ), indicating that maintaining total JNK activity is a vital for macrophages. Hence, to examine the effect of further genetic suppression of JNK signaling on atherosclerosis, we generated mice expressing a single allele of Jnk1 or Jnk2 in hematopoietic cells. Because the complete absence of both Jnk1 and Jnk2 causes early embryonic lethality, we intercrossed Jnk1 +/− /Jnk2 +/− mice and collected fetal liver cells. Then, 17-week-old male Ldlr −/− mice were lethally irradiated and reconstituted with male WT (n=10), Jnk1 −/− (n=10), Jnk1 +/− /Jnk2 −/− (n=13), and Jnk1 −/− /Jnk2 +/− (n=12) fetal liver cells. Four weeks after transplantation, these mice were challenged with the Western diet for 8 weeks. Again, there were no differences between the recipient groups in body weight and plasma lipid levels either on the chow or the Western diets (Table, B 
JNK1 Signaling Antagonizes Akt Activity in Macrophages
Next, we investigated the mechanism(s) responsible for the increased macrophage numbers in atherosclerotic lesions of Jnk1 −/− →Ldlr −/− mice by focusing on Akt signaling, which is crucial for cell survival. 20 In macrophages, Akt is constitutively activated, and inhibition of Akt signaling induces apoptosis. 27, 28 In addition, a recent report demonstrated that JNK activity antagonizes Akt signaling in some types of cells. 23 To examine whether JNK affects p-Akt in mouse macrophages, WT, Jnk1 −/− , and Jnk2 −/− peritoneal macrophages were treated with insulin alone or together with anisomycin, a known activator of JNK signaling. 23 Insulin significantly (2-3-fold) activated phosphorylation of both Akt sites (p-AktS 473 and T 308 ) in all types of cells ( Figure 3A) , whereas anisomycin suppressed Akt signaling activity in WT and Jnk2 −/− macrophages, respectively, with no changes in total Akt or β-actin content ( Figure 3A) . Importantly, Jnk1 −/− macrophages showed significantly less effect of JNK signaling on Akt activity than WT or Jnk2 −/− cells ( Figure 3B ). The analysis of p-AktS 473 /Akt and p-Akt T 308 /Akt ratio in the same blot indicated a similar protective effect of Jnk1 deficiency compared with WT or Jnk2 −/− cells ( Figure 3C and 3D). Direct comparison of WT and Jnk1 −/− macrophages treated with insulin and anisomycin demonstrated a statistically significant inhibitory effect of JNK signaling in the p-Akt/βactin ratio of WT but not of Jnk1 −/− macrophages ( Figure 3E and 3F). Thus, JNK1 is the isoform primarily responsible for JNK-mediated inhibition of Akt signaling in macrophages.
We also examined whether pharmacological inhibition of JNK can prevent the negative effects of JNK signaling on p-Akt. WT peritoneal macrophages were incubated with a mixture of insulin and anisomycin alone or in the presence of a JNK inhibitor. There was a 39% reduction of p-Akt levels in WT cells treated with anisomycin and a cell-permeable peptide inhibitor of JNK1, JNKI1, which preserved p-Akt levels in macrophages ( Figure 4A and 4B) . In contrast, treatment with a cell-permeable inhibitor IX, selective for JNK2 and JNK3 with little or no activity against JNK1, had no protective effects on Akt activity ( Figure 4A and 4B) . Taken together, these data indicate that genetic ablation and pharmacological inhibition of JNK1, but not JNK2, eliminate the suppressive effects of JNK signaling on Akt activity.
JNK1 Deficiency Protects Macrophages From Apoptosis
JNK signaling has proapoptotic or antiapoptotic functions, depending on the cell type, nature of the death stimulus, duration of its activation, and the activity of other signaling pathways. 17 Taking into consideration the critical role of Akt in cell survival, 20 we suggested that sustained JNK activation (1-6 hours) may promote apoptosis by exhausting antiapoptotic Akt signaling and by subsequently reducing Bad S 136 phosphorylation, which normally serves to inhibit apoptosis in macrophages. 27, 29 To test this hypothesis, we examined the effect of anisomycin on Akt signaling in WT and Jnk1 −/− macrophages treated with palmitic acid, a stress-mediated peritoneal macrophages were preincubated in serumfree media for 24 hours and then untreated or treated with insulin (100 nmol/L) alone or together with anisomycin (10 μg/mL) for 15 minutes. Macrophage proteins were extracted, resolved by electrophoresis (50 μg), and analyzed by Western blot. B-D, Ratio of p-AktS473/b-actin, p-AktS473/ Akt, and p-Akt T308/Akt in untreated (white color) or treated with insulin (green color) or insulin plus anisomycin (blue color). Graphs represent data (mean±SEM) of 3 experiments (*P<0.05 by 1-way ANOVA on rank compared with control WT cells treated with insulin together with anisomycin). E and F, WT and Jnk1 −/− macrophages were treated with insulin alone (green color) or together with anisomycin (blue color) for 10 and 15 minutes. Graphs represent data (mean±SEM) of 3 experiments (*P<0.05 by 1-way ANOVA on rank compared with WT cells treated with insulin). lipotoxic factor inducing endoplasmic reticulum (ER) stress and apoptosis. 30 The increased JNK signaling gradually suppressed p-Akt S 473 in WT cells, whereas Jnk1 −/− macrophages had higher p-Akt S 473 levels and were more resistant to p-Akt suppression ( Figure 4C and 4D) . Similarly, the treatment progressively reduced p-Bad S 136 levels in WT macrophages, but there was less attenuation of p-Bad S 136 in Jnk1 −/− cells ( Figure 4C ). Thus, compared with WT cells, Jnk1 −/− macrophages were able to preserve higher levels of Akt and Bad phosphorylation, which are important protective and antiapoptotic factors under conditions of ER stress. 31 In addition, to define the role of JNK signaling in macrophage apoptosis, WT, Jnk1 −/− , and Jnk2 −/− macrophages were treated with bovine serum albumin or palmitic acid. Treatment with bovine serum albumin generated only a few apoptotic TUNEL-positive (TUNEL + ) cells with no differences between cell types, whereas palmitic acid increased TUNEL + cells 4-fold in WT and Jnk2 −/− macrophages but not in Jnk1 −/− cells ( Figure 5A and 5B ). The addition of anisomycin markedly (3-fold) increased the percentage of TUNEL + cells to a similar degree in WT and Jnk2 −/− cells, whereas apoptosis was significantly reduced (57% of WT cells) in Jnk1 −/− macrophages ( Figure 5C ). In contrast, the selective inhibitor JNKI1 significantly (2-fold) reduced apoptosis in all types of cells, but Jnk1 −/− macrophages had less apoptosis than WT and Jnk2 −/− cells ( Figure 5D ). When WT macrophages were treated with the specific inhibitors of JNK, JNKI1, and SP600125, they demonstrated similar levels of apoptosis ( Figure 5E ). Importantly, when cells were loaded with human oxidized or acetylated LDL in combination with an ACAT (acetyl-coenzyme A acetyltransferase) inhibitor, Jnk1 −/− macrophages generated significantly less apoptosis than WT and Jnk2 −/− cells ( Figure 5F ). In addition, macrophages expressing a single Akt isoform ( Figure  III 
PTEN Suppression Impairs Effects of JNK Signaling on Akt Activity
Recently, Vivanco et al 26 have shown that JNK regulates p-Akt via PTEN, and Pten null mouse embryonic fibroblasts exhibit an impaired negative feedback loop. To test whether PTEN plays a critical role in regulating this pathway in mouse macrophages, WT and Pten −/− cells were treated with insulin alone or together with anisomycin. In contrast to WT cells, which showed increased p-Akt S 473 in response to insulin and reduced p-Akt S 473 after treatment with anisomycin, Pten −/− macrophages had markedly increased basal p-Akt, which was not suppressed in response to anisomycin ( Figure 6A and 6B) . Similarly, treatment with bpV(pic), a potent PTEN inhibitor, with an IC 50 ≈10to 100-fold lower than for other tyrosine phosphatases, 32 decreased the inhibitory effects of JNK on p-Akt ( Figure 6C and 6D) . Taken together, these results indicate that both genetic ablation and pharmacological inhibition of PTEN effectively eradicated JNK-mediated inhibition of Akt phosphorylation in mouse macrophages.
Discussion
Numerous studies have linked macrophage or hematopoietic JNK1 activity to insulin resistance and abnormal glucose homeostasis in obesity. 12, [33] [34] [35] These studies targeting individual JNK isoforms have produced varying degrees of effect in different models, perhaps because of interactions between isoforms and redundancies. 8 In fact, a recent report using Jnk1 and Jnk2-combined deletion has shown that macrophage JNK promotes the establishment of obesity-induced insulin resistance and pancreatic islet dysfunction. 12 These findings suggest that macrophage JNK signaling may be crucial in other pathological conditions and warrants detailed studies of individual isoforms in cardiovascular disease models. Here, we examined the effect of Jnk1 or Jnk2 deficiency in hematopoietic cells on early stages of atherosclerosis using the Ldlr-deficiency model. Mice reconstituted with Jnk1 −/− hematopoietic cells had significantly bigger atherosclerotic lesions compared with mice transplanted with WT or Jnk2 −/− marrow with no differences in serum lipids. Genetic ablation to a single Jnk allele (either Jnk1 +/− /Jnk2 −/− or Jnk1 −/− /Jnk2 +/− ) in hematopoietic cells further increased atherosclerosis compared with Jnk1 −/− →Ldlr −/− mice. We also found that JNK signaling antagonizes Akt activity in mouse macrophages acting mainly through JNK1. Therefore, Jnk1 −/− macrophages had less suppression of p-Akt in response to sustained ER stress and were protected from apoptosis. On the basis of these data, we conclude that this resistance to apoptotic stimuli in Jnk1 null macrophages increases lesion burden at the early stages of atherogenesis.
JNK signaling is overexpressed and activated in atherosclerotic lesions of cholesterol-fed rabbits. 36 Considering the role of JNK in inflammatory and metabolic responses, it is plausible that this stress-mediated JNK activation may affect macrophage viability and atherosclerosis. In fact, Ricci et al 16 were the first to report the involvement of JNK2 in atherosclerosis showing that Jnk2 −/− /apoE −/− mice developed less atherosclerosis compared with control apoE −/− and Jnk1 −/− /apoE −/− mice. They analyzed a later stage of atherosclerosis with more severe lesions induced by a high cholesterol (1.25%) diet for ). E, Percent of TUNEL + cells in WT macrophages untreated or treated with 0.5 mmol/L PA-BSA alone or together with JNK inhibitors, SP (100 nmol/L) or JNKI1 (3 μmol/L) for 24 hours (*P<0.05 by 1-way ANOVA on rank compared with untreated WT cells). F, Percent of TUNEL + in WT, Jnk1 −/− , and Jnk2 −/− macrophages untreated (control) or treated with human acetylated low-density lipoprotein (AcLDL; 100 μg/mL) in the presence of the ACAT (acetyl-coenzyme A acetyltransferase) inhibitor CP-113,818 (2 μg/mL) or human oxidized LDL (OxLDL; 100 μg/mL) for 48 hours (*P<0.05 compared with control WT cells treated with AcLDL by 1-way ANOVA on rank). 14 weeks in total body JNK isoform deficiency in the apoEdeficienct model on a hybrid C57BL6/129SV background, whereas in the current study, we explored early-stage atherosclerosis using Ldlr −/− mice on C57BL/6 background reconstituted with hematopoietic cells null for JNK isoforms and fed with the Western diet (containing 21% milk fat and 0.15% cholesterol) for 8 weeks. The variation in genetic background of mice, stage-specific lesion burden, and Jnk deficiency in specific compartments are all important determinants of cholesterol absorption 37 and susceptibility to atherosclerosis, 38 and they may underlie the apparent differences in our results.
In the current study, we observed a higher lesion burden in early atherosclerosis as a result of deficiency of Jnk1, but not Jnk2, in hematopoietic cells in the Ldlr null mice. Similar results were also obtained when combined deletion models (either Jnk1 +/− /Jnk2 −/− or Jnk1 −/− /Jnk2 +/− ) were used as donors to produce hematopoietic JNK deficiency. These results may point to several possibilities. For example, it is possible that total JNK activity may be a more important determinant of the effect on macrophage apoptosis and atherogenesis than separate JNK isoforms. In the future, it would be highly informative to examine interactions between JNK isoforms in supporting total JNK activity in vivo. In this sense, our data are consistent with a recent report, 39 indicating that loss of apoptosis signal-regulating kinase 1, which is upstream of JNK in certain contexts, in apoE null mice significantly reduced apoptosis and increased atherosclerosis by forming lesions enriched with macrophages. Because of the complexity of signaling upstream of JNK, multiple mechanisms may affect atherogenesis in a differential manner. For example, lack of mitogen-activated protein kinase phosphotase-1 protects apoE null mice from atherosclerosis, 40 whereas genetic deletion of Jnk1 reduces apoptosis in endothelial cells at atheroprone sites of the artery and thus diminishes atherosclerosis. 41 Similarly, the administration of anisomycin via osmotic minipump increased apoptosis and decreased the macrophage content in atherosclerotic lesions of rabbits. 42 In this scenario, prevention of macrophage death is likely a dominant feature of Jnk deficiency, at least during early stages of atherosclerosis, supporting the growth of vascular lesions enriched in macrophages. If this is the case, careful consideration of JNK's role in atherosclerosis and how it could be best used for therapeutic intervention would be well warranted. It is, however, equally likely that Jnk1 deficiency and early preservation of macrophage death may yield favorable functional outcomes by ensuring plaque stability and preventing rupture, the predominant cause of morbidity and mortality caused by atherosclerosis. 43 In fact, this would be quite reminiscent of the role of certain ER stress responses that are also related to macrophage death. 2 For example, C/EBP homologous protein deficiency can prevent macrophage death and support the stability of vascular lesions and prevent rupture. 44 Finally, it is possible that isolated examination of hematopoietic JNK activity only may have limitations and may not reflect the complete role of JNK in the pathogenesis of atherosclerosis. Future studies should dissect these possibilities in additional models.
Next, to identify the mechanism(s) responsible for the actions of JNK signaling in macrophages, we focused on the fact that Jnk1 −/− →Ldlr −/− mice had a dramatic decrease in apoptosis and increased numbers of macrophages in their atherosclerotic lesions compared with lesions of WT→Ldlr −/− and Jnk2 −/− →L dlr −/− mice. These results suggested that Jnk1 deficiency changes the balance between survival and proapoptotic signaling in macrophages at least in the setting they are examined. Indeed, our in vitro studies demonstrated that JNK signaling directly antagonizes Akt activity in mouse macrophages. This effect occurs within a short time (3-15 minutes) and may be beneficial for A and B, Akt signaling in wild-type (WT) and Pten −/− macrophages treated with insulin and anisomycin. Cells were preincubated with serum-free media for 16 hours and then untreated or treated with insulin alone (green color) or together with anisomycin (blue color) for the indicated time. Graphs represent data (mean±SEM) of 3 experiments (*P<0.05 between untreated and treated cells by 1-way ANOVA). C and D, PTEN inhibitor bpV(pig) preserves p-Akt signaling in WT peritoneal macrophages treated with anisomycin. Cells were preincubated in serum-free media for 24 hours and treated with insulin alone (green color) or with anisomycin (blue color) with or without bpV(pig) (0.1 μmol/L) for 15 minutes. Graphs represent data (mean±SEM) of 2 experiments (*P<0.05 by 1-way ANOVA on rank compared with cells treated with insulin). inflammatory and stress responses by diverting energy sources from the synthetic Akt pathway. 3 In contrast, prolonged or sustained JNK activation suppresses Akt signaling and induces cell apoptosis. 6 Interestingly, this antagonizing effect is mediated mainly through JNK1, but not JNK2, and genetic ablation or pharmacological inhibition of JNK1 completely obliterated this effect. These data are consistent with the previous reports, indicating that JNK signaling acts as a negative feedback loop that attenuates insulin action and insulin-induced PI3K activation. 7, 12, 23, [45] [46] [47] Together, our data indicate that JNK1 signaling antagonizes and suppresses Akt activity in mouse macrophages.
It is important to note that bone marrow transplantation may change every component of hematopoietic system in mice, including monocyte-macrophages, T and B cells, and platelets. Several studies have shown that JNK is required for effector T-cell function. 48 JNK2 is important for T-cell activation and apoptosis of immature thymocytes 49 and plays a role in control of CD8 + T-cell expansion in vivo, whereas JNK1 is involved in survival of activated T cells during immune responses. 50 Moreover, JNK1 is essential for platelet secretion and thrombus formation. 51 Therefore, we cannot exclude that these changes may also affect atherogenesis.
It is known that sustained JNK signaling restrains Akt activity, the major prosurvival signaling pathway that opposes apoptosis, 20 suggesting a potential mechanism for impaired macrophage viability. In our experiments, sustained JNK signaling under conditions of ER stress gradually extinguished Akt and Bad (S 136 ) activity in WT cells, whereas Jnk1 −/− macrophages were much less affected ( Figure 4C and 4D). Compared with WT cells, Jnk1 −/− macrophages were also protected from apoptosis initiated by different stimuli. Moreover, JNK1 inhibition distinctly decreased ER stress-mediated apoptosis in macrophages. These results are consistent with the concept that chronically activated JNK1 signaling is crucial in type 2 diabetes mellitus and obesity. 8, 11, 47, 52 JNK-mediated phosphorylation of insulin receptor substrates 1 and 2 disrupts Akt signaling 33, 46 possibly by releasing Bad for translocation to the mitochondria 23 or association with Bcl-2/Bcl-xL and initiation of apoptosis. In addition, we examined whether macrophages use a natural brake of Akt signaling, PTEN, to suppress p-Akt. Given that PTEN has been reported to cooperate with JNK 53 to couple the PI3K/Akt and JNK signaling pathways, 26 we examined whether PTEN mediates cross talk between these pathways in mouse macrophages. Our results demonstrate that genetic and pharmacological inhibition of PTEN virtually eradicates the JNKmediated effect on p-Akt in macrophages. Thus, JNK signaling may also act via PTEN to antagonize Akt activity and suppress macrophage survival. Macrophage-derived foam cells are the predominant cell type of early atherosclerotic lesions, and loss of macrophages through increased apoptosis may reduce the size of early atherosclerotic lesions. 54 Together, these data demonstrate that Jnk1 deficiency significantly increases macrophage survival, and this leads to cell accumulation in early-stage atherosclerotic lesions. Importantly, JNK and PTEN signaling in macrophages can be altered pharmacologically with the use of their ligands or inhibitors, supporting these pathways as new potential therapeutic targets for the prevention of atherosclerosis and allowing for functional studies in a stage-specific manner.
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